Xiaokun Li is Professor at Wenzhou Medical University, and has been vice director and associate professor at the Bioengineering Institute at Jinan University, China. He was among the first to study FGFs in China, and leads the largest dedicated research group in the world on the subject. In the past 20 years he has had new drugs and products approved by China SFDA. He has published 183 papers in leading international journals, and is the chair of the International Chinese FGF Association. He holds a PhD from Sun-Yat sen Medical University, and a degree in medical science from Norman Bethune Medical University in China.

• 1. Growth Factors Reviews2. Injury repair and Regeneration3. Endocrinology and Metabolism4. Structure and Modification5. Signaling Pathway and Pharmacology6. Pharmaceutics and New Material7. Bioreactor and Engineering8. FGF/FGFR and Inhibitors9. Others

Xiaokun Li is Professor at Wenzhou Medical University, and has been vice director and associate professor at the Bioengineering Institute at Jinan University, China. He was among the first to study FGFs in China, and leads the largest dedicated research group in the world on the subject. In the past 20 years he has had new drugs and products approved by China SFDA. He has published 183 papers in leading international journals, and is the chair of the International Chinese FGF Association. He holds a PhD from Sun-Yat sen Medical University, and a degree in medical science from Norman Bethune Medical University in China.

• 1. Growth Factors Reviews2. Injury repair and Regeneration3. Endocrinology and Metabolism4. Structure and Modification5. Signaling Pathway and Pharmacology6. Pharmaceutics and New Material7. Bioreactor and Engineering8. FGF/FGFR and Inhibitors9. Others

Xiaokun Li is Professor at Wenzhou Medical University, and has been vice director and associate professor at the Bioengineering Institute at Jinan University, China. He was among the first to study FGFs in China, and leads the largest dedicated research group in the world on the subject. In the past 20 years he has had new drugs and products approved by China SFDA. He has published 183 papers in leading international journals, and is the chair of the International Chinese FGF Association. He holds a PhD from Sun-Yat sen Medical University, and a degree in medical science from Norman Bethune Medical University in China.

• 1. Growth Factors Reviews2. Injury repair and Regeneration3. Endocrinology and Metabolism4. Structure and Modification5. Signaling Pathway and Pharmacology6. Pharmaceutics and New Material7. Bioreactor and Engineering8. FGF/FGFR and Inhibitors9. Others